Clinical Trial: NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06941857) titled 'NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer' on April 16.

Brief Summary: The purpose of this study is to evaluate safety of the treatment regimen and identify any novel toxicities.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: DRUG: Oxaliplatin

65mg/m2 will be administered as a 120 minute IV Infusion (-10/+ 20 minutes) on day 1 of each cycle every 2 weeks. Each cycle length is 14 days. The two arms will enroll sequentially (starting with Arm 1 followed by Arm 2).

DRUG: Irinotecan

15...